Hepatic oxidative DNA damage is associated with increased risk for hepatocellular carcinoma in chronic hepatitis C

por Tanaka, H, Fujita, N, Sugimoto, R, Urawa, N, Horiike, S, Kobayashi, Y, Iwasa, M, Ma, N, Kawanishi, S, Watanabe, S, Kaito, M, Takei, Y
Publicado 2008

Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group

por Kim, J G, Sohn, S K, Chae, Y S, Song, H S, Kwon, K-Y, Do, Y R, Kim, M K, Lee, K H, Hyun, M S, Ryoo, H M, Bae, S H, Park, K U, Lee, W S, Baek, J H, Chung, H Y, Yu, W
Publicado 2008

Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening

por Coupé, V M H, Berkhof, J, Bulkmans, N W J, Snijders, P J F, Meijer, C J L M
Publicado 2008

CYP1B1 expression is induced by docetaxel: effect on cell viability and drug resistance

por Martinez, V G, O'Connor, R, Liang, Y, Clynes, M
Publicado 2008

CD44(+)CD24(−) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis

por Hurt, E M, Kawasaki, B T, Klarmann, G J, Thomas, S B, Farrar, W L
Publicado 2008

Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancer

por Kaira, K, Oriuchi, N, Imai, H, Shimizu, K, Yanagitani, N, Sunaga, N, Hisada, T, Tanaka, S, Ishizuka, T, Kanai, Y, Endou, H, Nakajima, T, Mori, M
Publicado 2008

A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer:...

por Fruscio, R, Colombo, N, Lissoni, A A, Garbi, A, Fossati, R, Ieda', N, Torri, V, Mangioni, C
Publicado 2008

Prospective surveillance of women with a family history of breast cancer: auditing the risk threshold

por Anderson, E, Berg, J, Black, R, Bradshaw, N, Campbell, J, Carnaghan, H, Cetnarkyj, R, Drummond, S, Davidson, R, Dunlop, J, Fordyce, A, Gibbons, B, Goudie, D, Gregory, H, Holloway, S, Longmuir, M, McLeish, L, Murday, V, Miedzybrodska, Z, Nicholson, D, Pearson, P, Porteous, M, Reis, M, Slater, S, Smith, K, Smyth, E, Snadden, L, Steel, M, Stirling, D, Watt, C, Whyte, C, Young, D
Publicado 2008

Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer c...

por Akashi, Y, Okamoto, I, Iwasa, T, Yoshida, T, Suzuki, M, Hatashita, E, Yamada, Y, Satoh, T, Fukuoka, M, Ono, K, Nakagawa, K
Publicado 2008

Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastr...

por Matsubara, J, Nishina, T, Yamada, Y, Moriwaki, T, Shimoda, T, Kajiwara, T, Nakajima, T E, Kato, K, Hamaguchi, T, Shimada, Y, Okayama, Y, Oka, T, Shirao, K
Publicado 2008

Immunisation with ‘naïve’ syngeneic dendritic cells protects mice from tumour challenge

por Grimshaw, M J, Papazisis, K, Picco, G, Bohnenkamp, H, Noll, T, Taylor-Papadimitriou, J, Burchell, J
Publicado 2008

Laminin-332 promotes the invasion of oesophageal squamous cell carcinoma via PI3K activation

por Baba, Y, Iyama, K-i, Hirashima, K, Nagai, Y, Yoshida, N, Hayashi, N, Miyanari, N, Baba, H
Publicado 2008

Hypoxia-associated markers in gastric carcinogenesis and HIF-2α in gastric and gastro-oesophageal cancer prognosis

por Griffiths, E A, Pritchard, S A, McGrath, S M, Valentine, H R, Price, P M, Welch, I M, West, C M L
Publicado 2008

Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Onco...

por Tamura, K, Okamoto, I, Kashii, T, Negoro, S, Hirashima, T, Kudoh, S, Ichinose, Y, Ebi, N, Shibata, K, Nishimura, T, Katakami, N, Sawa, T, Shimizu, E, Fukuoka, J, Satoh, T, Fukuoka, M
Publicado 2008

Educational differences in cancer mortality among women and men: a gender pattern that differs across Europe

por Menvielle, G, Kunst, A E, Stirbu, I, Strand, B H, Borrell, C, Regidor, E, Leclerc, A, Esnaola, S, Bopp, M, Lundberg, O, Artnik, B, Costa, G, Deboosere, P, Martikainen, P, Mackenbach, J P
Publicado 2008

Second malignancies after breast cancer: the impact of different treatment modalities

por Kirova, Y M, De Rycke, Y, Gambotti, L, Pierga, J-Y, Asselain, B, Fourquet, A
Publicado 2008

Early detection of recurrence by (18)FDG-PET in the follow-up of patients with colorectal cancer

por Sobhani, I, Tiret, E, Lebtahi, R, Aparicio, T, Itti, E, Montravers, F, Vaylet, C, Rougier, P, André, T, Gornet, J M, Cherqui, D, Delbaldo, C, Panis, Y, Talbot, J N, Meignan, M, Le Guludec, D
Publicado 2008

A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumours

por Blagden, S P, Molife, L R, Seebaran, A, Payne, M, Reid, A H M, Protheroe, A S, Vasist, L S, Williams, D D, Bowen, C, Kathman, S J, Hodge, J P, Dar, M M, de Bono, J S, Middleton, M R
Publicado 2008

Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer

por Suzuki, H, Toyota, M, Caraway, H, Gabrielson, E, Ohmura, T, Fujikane, T, Nishikawa, N, Sogabe, Y, Nojima, M, Sonoda, T, Mori, M, Hirata, K, Imai, K, Shinomura, Y, Baylin, S B, Tokino, T
Publicado 2008

High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell l...

por Kim, D-W, Min, H S, Lee, K-H, Kim, Y J, Oh, D-Y, Jeon, Y K, Lee, S-H, Im, S-A, Chung, D H, Kim, Y T, Kim, T-Y, Bang, Y-J, Sung, S W, Kim, J H, Heo, D S
Publicado 2008